Liverpool Skyline

Public Health Institute

Mr James McVeigh

Mr James McVeigh

Telephone: 0151 231 4512

Biography

Jim McVeigh was appointed as the Director of Public Health Institute in November 2015. Jim has worked within health/public health for nearly 30 years, with an academic career starting in the University of Liverpool before moving to Liverpool John Moores University as a Research Assistant in 1999. Subsequently he has held various positions within Public Health including Senior Lecturer, Reader, Deputy Director and most recently, Acting Director. He has gained significant management skills and leadership experience, while developing extensive links with external organisations and stakeholders at local, national and international level. Jim has an international reputation within his academic specialism of human enhancement drug use and has co-authored more than 100 research reports, 50 peer reviewed papers and been invited to deliver keynote presentations and plenary papers at some of the most influential national and international conferences.

Publications

Highlighted publications

Hope VD, Harris R, McVeigh J, Cullen KJ, Smith J, Parry JV, DeAngelis D, Ncube F. 2016. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 71 :331-337 >DOI >Link

Abbate V, Kicman AT, Evans-Brown M, McVeigh J, Cowan DA, Wilson C, Coles SJ, Walker CJ. 2015. Anabolic steroids detected in bodybuilding dietary supplements - a significant risk to public health DRUG TESTING AND ANALYSIS, 7 :609-618 >DOI >Link

Breindahl T, Evans-Brown M, Hindersson P, McVeigh J, Bellis M, Stensballe A, Kimergard A. 2015. Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet DRUG TESTING AND ANALYSIS, 7 :164-172 >DOI >Link

Hope VD, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergard A, Parry JV, Ncube F. 2015. Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking EPIDEMIOLOGY AND INFECTION, 143 :132-140 >DOI >Link

Reports

Whitfield M, McVeigh J, Reed H, Harrison R, Leech C. 2017. Integrated Monitoring System Annual Report - Cheshire and Merseyside, 2016-17 Integrated Monitoring System Annual Report - Cheshire and Merseyside, 2016-17 >Link

Begley E, McVeigh J, Hope VD, Bates G, Glass R, Campbell J, Tanner C, Kean J, Morgan G, Acreman D, Smith J. 2017. Image and Performance Enhancing Drugs 2016 National Survey Results Image and Performance Enhancing Drugs 2016 National Survey Results

Critchley K, Collins P, Cuddy K, Whitfield M, McVeigh J. 2016. Merseyside Annual DIP Report: DIP Activity (April 2014 – March 2015) Merseyside Annual DIP Report: DIP Activity (April 2014 – March 2015)

Bates G, McVeigh J. 2016. Image and Performance Enhancing Drugs 2015 Survey Results

McCoy EJ, Oyston J, Ross-Houle K, COCHRANE M, BATES G, JONES L, WHITFIELD M, MCVEIGH J. 2016. Evaluation of the Liverpool REST Centre

McVeigh J, bates G, chandler M. 2015. Steroids and Image Enhancing Drugs 2014 Survey Results >Link

Harris J, Lincoln A, Whitfield M, McVeigh J. 2015. HIV and AIDS in Cumbria & Lancashire: HIV and AIDS in the North West of England 2014. HIV and AIDS in Cumbria & Lancashire: HIV and AIDS in the North West of England 2014. >Link

Cuddy K, Collins P, Whitfield M, McVeigh J. 2015. DIP Merseyside Demographic Report 2013/14: An evaluation of DIP’s Impact on Offending. DIP Merseyside Demographic Report 2013/14: An evaluation of DIP’s Impact on Offending >Link

Whitfield M, Reed H, Harrison R, McVeigh J. 2015. Integrated Monitoring System Annual Report Cheshire and Merseyside 2014/15 Integrated Monitoring System Annual Report Cheshire and Merseyside 2014/15 >Link

McVeigh J, Bates G, Chandler M. 2015. Steroids and Image Enhancing Drugs 2014 Survey Results

Collins P, Cuddy K, Whitfield M, McVeigh J. 2015. DIP Merseyside Drug Testing Report (April 2013 - March 2014) DIP Merseyside Drug Testing Report (April 2013 - March 2014)

Whitfield M, Reed H, Harrison R, Davies C, McVeigh J. 2014. Drug and Alcohol Treatment in Cheshire & Merseyside 2012/13 Drug and Alcohol Treatment in Cheshire & Merseyside 2012/13

Whitfield M, Reed H, Harrison R, Davies C, McVeigh J. 2014. Integrated Monitoring System Annual Report Cheshire and Merseyside 2013/14 Integrated Monitoring System Annual Report Cheshire and Merseyside 2013/14

Bates G , Jones L , McVeigh J. 2014. Analysis of survey data on the implementation of NICE PH18 guidance relating to needle and syringe provision in England Analysis of survey data on the implementation of NICE PH18 guidance relating to needle and syringe provision in England

Chandler M , McVeigh J. 2014. Steroids and Image Enhancing Drugs 2013 Survey Results

Whitfield M, Reed H, Harrison R, Davies C, McVeigh J. 2014. Merseyside & Cheshire Inter-Agency Drug Misuse Database (IAD) Needle and Syringe Programme 2012-13 Merseyside & Cheshire Inter-Agency Drug Misuse Database (IAD) Needle and Syringe Programme 2012-13

Harris J, Lincoln A, Whitfield M, McVeigh J. 2014. HIV and AIDS in the North West of England 2013 HIV and AIDS in the North West of England 2013 :1-91 >Link

McCoy E, Jones L, McVeigh J. 2013. Evaluation of the Liverpool Women’s Turnaround Project >Link

Davies C, English L, Stewart C, McVeigh J, Bellis M. 2013. United Kingdom Drug Situation: annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2012 >Link

Hurst A, Marr A, Whitfield M, McVeigh J. 2013. Alcohol Treatment in Cheshire and Merseyside, 2011/12 >Link

Bates G, Jones L, McVeigh J. 2013. Update of NICE Guidance PH18 on 'Needle and Syringe programmes. PIEDs Review. >Link

McCoy E, Jones L, McVeigh J. 2013. Evaluation of the Liverpool Women’s Turnaround Project: Moving forward >Link

Harris J, Hargreaves S, Lincoln A, McVeigh J. 2013. HIV & AIDS in the North West of England 2012

Harris J, Hargreaves S, Lincoln A, McVeigh J. 2012. HIV & AIDS in the North West of England 2011

Howarth P, Duffy P. 2012. Merseyside DIP OCU Report (April 2007 - March 2011) Merseyside DIP OCU Report (April 2007 - March 2011)

Hurst A, Beynon C, Hughes S, Marr A, McVeigh J. 2012. NDTMS themed report: Patterns of mortality amongst injecting and non-injecting drug users in contact with treatment services in the North West of England, 2003/04-2005/06. >Link

Brizell J, Stuart J, McVeigh J, Irvine F. 2012. Patient perspectives of the CHANGES weight management service. >Link

Brizell J, Stuart J, McVeigh J, Irvine F. 2012. Evaluation of the Bariatric Care Pathway: Prospective Patients >Link

Brizell J, Stuart J, McVeigh J, Irvine F. 2012. Evaluation of the CHANGES weight management programme: Prospective Patients >Link

Brizell J, Harrison R, Stuart J, McVeigh J, Irvine F. 2012. Evaluation of the Bariatric Care Pathway:Final Report >Link

Brizell J, Harrison B, Stuart J, McVeigh J, Irvine F. 2012. CHANGES Weight Management Service Evaluation: Final Report >Link

Harris J, Hargreaves S, Lincoln A, McVeigh J, Syed Q, Bellis M. 2012. HIV & AIDS In the North West of England 2011 >Link

Hurst A, Marr A, Whitfield M, McVeigh J. 2012. Alcohol Treatment in Cheshire and Merseyside, 2010/11 >Link

Duffy P, Russell S, McGee A, McVeigh J. 2012. Evaluation of a Residential Alcohol Detoxification Programme Facilitated by The Basement:Safety, Perceptions and Effectiveness >Link

Bates G, Chadborn N, Jones L, McVeigh J. 2012. The impact of Climate Change upon Health and Health Inequalities in the North West of England The impact of Climate Change upon Health and Health Inequalities in the North West of England

Evans-Brown M, McVeigh J, Perkins C, Bellis MA. 2012. Human Enhancement Drugs - The Emerging Challenges to Public Health Human Enhancement Drugs - The Emerging Challenges to Public Health

Davies C, English L, Stewart C, Lodwick A, McVeigh J, Bellis M. 2011. United Kingdom Drug Situation 2011 EDITION UK Focal Point On Drugs >Link

Gibbons C, Marr A, McVeigh J. 2011. Structured alcohol treatment in the North West of England 2009/10 Results from the National Drug Treatment Monitoring System (NDTMS) >Link

Stuart J, Brizell J, Irvine F, McVeigh J. 2011. Stakeholder Perceptions of the Bariatric Care Pathway on the Wirral >Link

Stuart J, Brizell J, McVeigh J, Irvine F. 2011. Patient perspectives of the Bariatric Care Pathway on the Wirral >Link

Jones L, Bates G, McCoy E, Beynon C, McVeigh J, Bellis M. 2011. A systematic review of the effectiveness & cost-effectiveness of interventions aimed at raising awareness and engaging with groups who are at an increased risk of hepatitis B and C infection. >Link

Jones L, Atkinson A, Porcellato L, Bates G, McCoy E, Beynon C, McVeigh J, Bellis M. 2011. A systematic review of qualitative research on the views, perspectives and experiences of hepatitis B and C testing among practitioners and people at greatest risk of infection. >Link

Brizell J, Stuart J, McVeigh J, Irvine F. 2011. Stakeholder perceptions of the CHANGES weight management service >Link

Jones L, Bates G, Bellis MA, Beynon C, Duffy P, Evans-Brown M, Mackridge A, McCoy E, Sumnall H, McVeigh J. 2011. A Summary of the Health Harms of Drugs A Summary of the Health Harms of Drugs >Link

Cole C, McVeigh J. 2010. Evaluation of the Rapid Access Homeless Outreach Service >Link

Davies C, English L, Lodwick A, McVeigh J, Bellis M. 2010. United Kingdom Drug Situation 2009 EDITION >Link

McCoy E, Hurst A, Marr A, Whitfield M, McVeigh J, Bellis M. 2010. Alcohol Treatment in Cheshire and Merseyside 2008/09 >Link

Hurst A, Marr A, McCoy E, McVeigh J, Bellis M. 2010. Drug and alcohol treatment in the North West of England 2008/09. Results from the National Drug Treatment Monitoring System (NDTMS). Liverpool: Liverpool John Moores University >Link

Jones L, Woolfall K, Porcellato L, McVeigh J. 2009. Evidence relating to new tobacco control priorities that aim to protect children and young people from exposure to tobacco Evidence. >Link

Jones L, Woodfall K, Porcellato L, McVeigh J. 2009. The impact of advocacy initiatives led by, or on the behalf of, young people. A systematic map and summary of the evidence. >Link

McCoy E, McVeigh J, Khundakar K, Hurst A, Bellis M. 2009. Alcohol Treatment in Cheshire & Merseyside 2007/08 >Link

Russell S, Shaw C, McVeigh J. 2009. Evaluation of Phase Two of the Liverpool Peer to Peer Project May 2009 >Link

Cole C, Hurst A, McVeigh J, Bellis M. 2009. Indications of Public Health in the English Regions 10: Drug Use >Link

Cole C, Hurst A, McVeigh J, Bellis M. 2009. Indications of Public Health in the English Regions 10: Drug Use Executive Summary >Link

Hurst A, Parker H, Marr A, McVeigh J. 2009. NDTMS Themed Report AACCE (non-opiate) substance use in the North West of England >Link

Hurst A, Beynon C, Marr A, McVeigh J. 2009. NDTMS Themed Report Patterns of mortality amongst individuals in contact with drug treatment services in the North West of England - 5 years of data capture. >Link

Warering M, McVeigh J, Sumnall H. 2008. Young People and Cannabis use in Liverpool. >Link

Hurst A, Beynon C, Marr A, McVeigh J. 2008. NDTMS Themed Report Does the North West of England have an ageing drug treatment population? >Link

Eaton G, Davies C, English L, Lodwick A, Bellis M, McVeigh J. 2008. United Kingdom Focal Point Report 2007 >Link

Cole C, McVeigh J. 2008. Needs Assessment with Homeless Drug and Alcohol Users in Liverpool >Link

Hurst A, Marr A, McVeigh J, Bellis M. 2008. Drug treatment in the North West of England 2007/08 >Link

Hurst A, Woolfall K, Marr A, McVeigh J. 2008. NDTMS Themed Report Parental Status, 2007/08 >Link

Woodfall K, Sumnall H, McVeigh J. 2008. Addressing the needs of children of substance using parents: an evaluation of Families First’s Intensive Intervention Final Report. >Link

Jones L, Pickering L, Sumnull H, McVeigh J, Bellis M. 2008. A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users. >Link

Eaton G, Davies C, English L, Lodwick A, McVeigh J, Bellis M. 2008. United Kingdom Focal Point Report 2008. >Link

Khundakar A, Sumnall H, Marr A, McVeigh J, Bellis A. 2007. Individuals aged under 25 in contact with treatment services in the North West of England during 2005/06. >Link

Fordham R, Jones L, Sumnall H, McVeigh J, Bellis M. 2007. The economics of preventing drug use: An introduction to the issues. Richard Fordham, Lisa Jones, Harry Sumnall, Jim McVeigh and Mark Bellis >Link

Eaton G, Lodwick A, Bellis M, McVeigh J. 2007. United Kingdom drug situation: annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2006. >Link

Hurst A, Beynon C, Hughes S, Marr A, McVeigh J. 2007. NDTMS themed report: Patterns of mortality amongst injecting and non-injecting drug users in contact with treatment services in the North West of England, 2003/04-2005/06 >Link

Khundakar A, Duffy P, Marr A, McVeigh J. 2007. NDTMS Themed Report Referrals into structured drug treatment in the North West of England from the Criminal Justice System 2005/06 >Link

Chandler M, Shepherd E, Mcveigh J. 2007. Inter Agency Drug Misuse Database 2005/06 >Link

Shaw C, Salmon J, McVeigh J. 2007. Evaluation of the Peer to Peer Project. >Link

Khundakar A, Morleo M, Khundakar K, Marr A, McVeigh J, Bellis M. 2007. Individuals stating alcohol as a secondary or tertiary problematic substance in contact with treatment services in the North West during 2006/07 >Link

McCoy E, McVeigh J, Morleo M, Khundakar K, Bellis M. 2007. Alcohol Treatment in Cheshire And Merseyside 2006/07 >Link

Wareing M, McVeigh J, Sumnall H. 2007. Young People and Substance Misuse: Characteristics, Needs and Perception of Treatment Services of Drug Users Aged 18 to 25 in Liverpool. >Link

Hurst A, Morleo M, Khundakar K, Marr A, McVeigh J, Bellis M. 2007. Results from the National Drug Treatment Monitoring System [NDTMS] 2006/07 >Link

McCoy E, McVeigh J, Morleo M, Khundakar K, Bellis M. 2007. Alcohol Treatment In Cheshire And Merseyside 2006/07. >Link

Hughes KE, Morleo M, McVeigh J. 2007. Evaluation of Preston’s alcohol brief intervention training pack: ‘Train the Trainers’

Sumnall H, McGrath Y, McVeigh J, Burrell K, Wilkinson L, Bellis M, Reid D. 2006. Drug use prevention among young people Evidence into practice briefing. >Link

McGrath Y, Sumnall H, McVeigh J, Bellis M. 2006. Drug use prevention among young people: a review of reviews. >Link

Jones L, Sumnall H, Witty K, Wareing M, McVeigh J, Bellis M. 2006. A review of community-based interventions to reduce stance misuse among vulnerable and disadvantaged young people. >Link

Brown S, McVeigh J, Beynon C, Bellis M. 2006. Alcohol Treatment In Cheshire & Merseyside 2004/05. >Link

Burrell K, Sumnall H, Witty C, McVeigh J. 2006. Alcohol Brief Intervention >Link

Sumnall H, McGrath Y, McVeigh J, Burrell K, Wilkinson L, Bellis M. 2006. Drug use prevention among young people Evidence into practice briefing. >Link

CHANDLER M, SHEPHERD E, McVeigh J. 2006. Merseyside Inter Agency Drug Misuse Database Annual Report 2004/05 >Link

Jones L, Sumnall H, Burrell K, McVeigh J, Bellis M. 2006. Universal Drug Prevention. >Link

Jones L, Sumnall H, Burrell K, McVeigh J, Bellis M. 2006. Universal Drug Prevention - Fact Sheets >Link

McGrath Y, Sumnall H, Edmonds K, McVeigh J, Bellis M. 2006. Review of grey literature on drug prevention among young people. >Link

McGrath Y, Sumnall H, Burrell K, McVeigh J, Bellis M. 2006. Review of grey literature on drug prevention among young people Review Summary. >Link

Sumnall H, Jones L, Burrell K, Witty K, McVeigh J, Bellis M. 2006. Annual review of Drug Prevention The National Collaborating Centre for Drug Prevention. >Link

Khundakar A, Marr A, McVeigh J, Bellis M. 2006. Drug treatment in the North West of England 2005/06 >Link

Khundakar A, Beynon C, Marr A, McVeigh J, Bellis M. 2006. Deaths of those in contact with drug treatment services in the North West of England for the reporting period 2003/04 and 2004/05. >Link

McVeigh J, Morleo M, Khundakar K, Beynon C, Bellis M. 2006. Alcohol Treatment in Cheshire & Merseyside 2005/06 >Link

Bullock T, Weston S, McVeigh J, Bellis M. 2005. Drug treatment in the North West of England, 2003/04. >Link

Sumnall H, Cook L, McGrath Y, Wilkinson L, McVeigh J, Bellis M, Burrell K. 2005. Drug Prevention Quarterly - April 2005. >Link

Eaton G, Morleo M, Lodwick A, Bellis M, McVeigh J. 2005. United Kingdom Drug Situation: 2004 Edition. >Link

Hurst A, Beynon C, McVeigh J. 2005. Evaluation of Lighthouse Project Opening >Link

Burrell K, Sumnall H, McVeigh J, Bellis M. 2005. Drug Prevention vulnerable young people. >Link

Burrell K, Sumnall H, McVeigh J, Bellis M. 2005. Drug Prevention - Fact Sheet >Link

Sumnall H, Burrell K, Jones L, Wilkinson L, McVeigh J, Bellis M. 2005. Drug Prevention Quarterly September 2005. >Link

BURRELL K, Jones L, SUMNALL H, McVeigh J, Bellis M. 2005. Tiered approach to Drug Prevention and treatment among young people. >Link

Quigg ZA, Beynon C, Edwards S, Morleo M, McVeigh J. 2005. Drink Spiking Report

Roberts L, McVeigh J. 2004. LIFEGUARD: ACT FAST SAVE A LIFE. Evaluation >Link

Roberts L, McVeigh J. 2004. LIFEGUARD: ACT FAST SAVE A LIFE. Evaluation Executive Summary. >Link

Beynon C, McVeigh J, Bellis M. 2004. Quantifying Problematic Drug Use Within Liverpool and Sefton (2000-2) Summary. >Link

Beynon C, McVeigh J, Bellis M. 2004. Problematic Drug Use Within Liverpool and Sefton. >Link

Bellis M, Morleo M, Wood S, McVeigh J, Lodwick A, Eaton G, Donnelly S. 2004. United Kingdom Drug Situation:2002 >Link

Cook L, McGrath Y, Wilkinson L, Sumnall H, McVeigh J, Bellis M, Burrell K. 2004. Drug Prevention Quarterly - November 2004. >Link

Chandle M, McVeigh J, Bullock T, Duffy P. 2004. Merseyside Inter Agency Drug Misuse Database 2003/04. >Link

Beynon C, McVeigh J, Bellis M. 2003. Drug Treatment in Cheshire & Merseyside - The first year of the National Drug Treatment Monitoring System (NDTMS) 2001/02. >Link

McVeigh J, Hughes KE, Hounsome J, Bellis M. 2003. Over a Decade of Drug Use Epidemiology

McVeigh J. 2002. Shaping a New Agenda. >Link

McVeigh J, Duffy P. 2002. The Independence Initiative. An Evaluation of Effectiveness, >Link

McVeigh J, Cook P, Rimmer P, Syed Q, Bellis M. 2000. HIV and AIDS in the North West of England 1999 Executive Summary >Link

McVeigh J, Cook P, Rimmer P, Syed Q, Bellis A. 2000. HIV and AIDS in the North West of England 1999 - Full Report. >Link

Cook P, McVeigh J, Patel A, Syed Q, Mutton K, Bellis M. 2000. Hepatitis C in injecting drug users in the NorthWest - Full Report. >Link

Cook P, McVeigh J, Patel A, Syed Q, Mutton K, Bellis M. 2000. Hepatitis C in injecting drug users in the North West - Executive Summary. >Link

McVeigh J, Rimmer P, Syed Q, Bellis M. 1999. HIV & AIDS in the North West of England 1998. >Link

McVeigh J, Rimmer P, Syed Q, Bellis M. 1988. HIV and AIDS in the North West of England 1997. >Link

Cochrane M, McCoy E, Timpson H, McVeigh J. Evaluation of the Stand Against Violence Workshop

Davies C, Enlish L, Stewart C, Lodwick A, McVeigh J, Bellis MA. United Kingdom Drug Situation 2011 Edition: Annual Report to the European Monitoring Centre for Drugs and Drug Addiction. United Kingdom Drug Situation 2011 Edition: Annual Report to the European Monitoring Centre for Drugs and Drug Addiction. >Link

Davies C, English L, Lodwick A, McVeigh J, Bellis MA. United Kingdom Drug Situation 2010 Edition: Annual Report to the European Monitoring Centre for Drugs and Drug Addiction. >Link

Hurst A, Marr A, McVeigh J. Revisiting the AACCE profile in the North West of England. Results from NDTMS in 2008/09. Liverpool John Moores University >Link

McVeigh J, Shaw C, Jones L, Kicman A, Syed Q. Cut: A Guide to Adulterants, Bulking Agents and Other Contaminants Found in Illicit Drugs Cut: A Guide to Adulterants, Bulking Agents and Other Contaminants Found in Illicit Drugs >Link

Cole C, Wooding O, Russell S, Hennessey C, McVeigh J. Patterns of Substance Use & Support Needs of Residents in Young People’s Hostels & Foyer Accommodation in Liverpool

Burrows M, Elliott G, Morleo M, Marr A, McVeigh J. Offender Health: alcohol services review >Link

Hurst A, Beynon C, Marr A. Patterns of mortality amongst individuals in contact with drug treatment services in the North West of England >Link

Jones L, Bates G, McCoy E, Wooding O, McVeigh J, Bellis MA. Positive and negative impacts of the nuclear industry on health and well-being: Scoping review Positive and negative impacts of the nuclear industry on health and well-being: Scoping review

Journal Articles

Bates G, Begley E, Tod D, Jones L, Leavey C, McVeigh J. 2017. A systematic review investigating the behaviour change strategies in interventions to prevent misuse of anabolic steroids. J Health Psychol, :1359105317737607 >DOI >Link

Hope VD, McVeigh J, Smith J, Glass R, Njoroge J, Tanner C, Parry JV, Ncube F, Desai M. 2017. Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15 DRUG AND ALCOHOL DEPENDENCE, 179 :83-86 >DOI >Link

Bates G, Hope V, McVeigh J. 2017. HIV among people using anabolic steroids in the United Kingdom: an overview HIV Nursing, 17 :20-23

Zahnow R, McVeigh J, Ferris J, Winstock A. 2017. Adverse Effects, Health Service Engagement, and Service Satisfaction Among Anabolic Androgenic Steroid Users Contemporary Drug Problems, 44 :69-83 >DOI

McVeigh J, Begley E. 2017. Anabolic steroids in the UK: an increasing issue for public health DRUGS-EDUCATION PREVENTION AND POLICY, 24 :278-285 >DOI >Link

McVeigh J, Germain J, Van Hout MC. 2017. 2,4-Dinitrophenol, the inferno drug: a netnographic study of user experiences in the quest for leanness JOURNAL OF SUBSTANCE USE, 22 :131-138 >DOI >Link

McVeigh J, Hearne E, Bates G, Van Hout MC. 2016. Community pharmacist experiences of providing needle and syringe programmes in Ireland Research in Social and Administrative Pharmacy, >DOI

Hearne E, Grund J-PC, Van Hout MC, McVeigh J. 2016. A scoping review of home-produced heroin and amphetamine-type stimulant substitutes: implications for prevention, treatment, and policy HARM REDUCTION JOURNAL, 13 >DOI >Link

Iversen J, Hope VD, McVeigh J. 2016. Access to needle and syringe programs by people who inject image and performance enhancing drugs INTERNATIONAL JOURNAL OF DRUG POLICY, 31 :199-200 >DOI >Link

Hope VD, Harris R, McVeigh J, Cullen KJ, Smith J, Parry JV, DeAngelis D, Ncube F. 2016. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 71 :331-337 >DOI >Link

Abbate V, Kicman AT, Evans-Brown M, McVeigh J, Cowan DA, Wilson C, Coles SJ, Walker CJ. 2015. Anabolic steroids detected in bodybuilding dietary supplements - a significant risk to public health DRUG TESTING AND ANALYSIS, 7 :609-618 >DOI >Link

Breindahl T, Evans-Brown M, Hindersson P, McVeigh J, Bellis M, Stensballe A, Kimergard A. 2015. Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet DRUG TESTING AND ANALYSIS, 7 :164-172 >DOI >Link

Hope VD, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergard A, Parry JV, Ncube F. 2015. Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking EPIDEMIOLOGY AND INFECTION, 143 :132-140 >DOI >Link

Kimergard A, McVeigh J, Knutsson S, Breindahl T, Stensballe A. 2014. Online marketing of synthetic peptide hormones: poor manufacturing, user safety, and challenges to public health DRUG TESTING AND ANALYSIS, 6 :396-398 >DOI >Link

Kimergard A, McVeigh J. 2014. Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study HARM REDUCTION JOURNAL, 11 >DOI >Link

Jones L, Atkinson A, Bates G, McCoy E, Porcellato L, Beynon C, McVeigh J, Bellis MA. 2014. Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: Systematic review of qualitative research International Journal of Drug Policy, 25 :204-211 >DOI

Kimergard A, McVeigh J. 2014. Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK BMJ OPEN, 4 >DOI >Link

Kimergard A, Breindahl T, Hindersson P, McVeigh J. 2014. The composition of anabolic steroids from the illicit market is largely unknown: implications for clinical case reports QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 107 :597-598 >DOI >Link

Evans-Brown M, Kimergard A, McVeigh J, Chandler M, Brandt SD. 2014. BODYBUILDING SUPPLEMENTS Is the breast cancer drug tamoxifen being sold as a bodybuilding dietary supplement? BMJ-BRITISH MEDICAL JOURNAL, 348 >DOI >Link

Jones L, Bates G, McCoy E, Beynon C, McVeigh J, Bellis MA. 2014. Effectiveness of interventions to increase hepatitis C testing uptake among high-risk groups: a systematic review. Eur J Public Health, 24 :781-788 >DOI >Link

Hope VD, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergård A, Croxford S, Beynon CM, Parry JV, Bellis MA, Ncube F. 2013. Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study. BMJ Open, 3 :e003207 >DOI >Link

Hope V, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergard A, Croxford S, Beynon C, Parry J, Bellis PM, Ncube F. 2013. Prevalence of, and risk factors for, human immunodeficiency virus, hepatitis B and hepatitis C infections among men who inject image- and performance-enhancing drugs in England & Wales HIV MEDICINE, 14 :2-2 >Link

McVeigh J, Evans-Brown M, Bellis MA. 2012. Human enhancement drugs and the pursuit of perfection ADICCIONES, 24 :185-190 >Link

Sumnall HR, Evans-Brown M, McVeigh J. 2011. Social, policy, and public health perspectives on new psychoactive substances. Drug Test Anal, 3 :515-523 >DOI >Link

Evans-Brown MJ, Bellis MA, McVeigh J. 2011. Should “legal highs” be regulated as medicinal products? BMJ, 342 :d1101

Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. 2011. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal, 3 :89-96 >DOI >Link

Russell SJ, McVeigh J. 2011. Next generation challenges: an overview of Harm Reduction 2010, IHRA's 21st conference. Int J Drug Policy, 22 :82-86 >DOI >Link

Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. 2010. Optimal provision of needle and syringe programmes for injecting drug users: A systematic review Int J Drug Policy, 21 :335-342 >DOI

Beynon C, McVeigh J, Hurst A, Marr A. 2010. Older and sicker: Changing mortality of drug users in treatment in the North West of England. Int J Drug Policy, 21 :429-431 >DOI >Link

Chandler MD, McVeigh J, Beynon CM. 2010. Integrating drug related monitoring systems – An intelligence led approach Contemporary Drug Problems, 36 :663-683

Mackridge AJ, Beynon CM, McVeigh J, Whitfield M, Chandler M. 2010. Meeting the health needs of problematic drug users through community pharmacy: A qualitative study JOURNAL OF SUBSTANCE USE, 15 :367-376 >DOI >Link

Mackridge AJ, Beynon C, McVeigh J. 2009. Pharmacy services must be expanded if guidelines are to be successfully implemented British Medical Journal,

McVeigh J, Evans-Brown MJ. 2009. Anabolic steroids Network, 25

Evans-Brown M, McVeigh J. 2009. Injecting human growth hormone as a performance-enhancing drug-perspectives from the United Kingdom JOURNAL OF SUBSTANCE USE, 14 :267-288 >DOI >Link

Evans-Brown M, Kimergard A, McVeigh J. 2009. Elephant in the room? The methodological implications for public health research of performance-enhancing drugs derived from the illicit market DRUG TESTING AND ANALYSIS, 1 :323-326 >DOI >Link

Evans-Brown M, Dawson RT, Chandler M, McVeigh J. 2009. Use of melanotan I and II in the general population BRITISH MEDICAL JOURNAL, 338 >DOI >Link

Beynon CM, McVeigh C, McVeigh J, Leavey C, Bellis MA. 2008. The involvement of drugs and alcohol in drug-facilitated sexual assault: a systematic review of the evidence. Trauma Violence Abuse, 9 :178-188 >DOI >Link

Evans-Brown M, Dawson R, McVeigh J. 2008. The dire consequences of doping? Lancet, 372 :1544-1544 >DOI

Evans-Brown MJ, McVeigh J. 2008. An Introduction to anabolic steroids Sportex Medicine, :20-26

Beynon CM, McVeigh J. 2007. The role of Substance use in non-drug related deaths:a cross sectional study of drug treatment clients in the North West of England Journal of Substance Use, :39-47

Beynon CM, McVeigh J, Roe B. 2007. Problematic drug use, ageing and older people: trends in the age of drug users in northwest England AGEING & SOCIETY, 27 :799-810 >DOI >Link

Beynon CM, McVeigh J, Chandler M, Wareing M, Bellis MA. 2007. The impact of citrate introduction at UK syringe exchange programmes: a retrospective cohort study in Cheshire and Merseyside, UK. Harm Reduct J, 4 :21 >DOI >Link

Beynon C, Sumnall HR, McVeigh J, Cole JC, Bellis MA. 2006. Drink detective: Comments on the manufacturer's response ADDICTION, 101 :1395-1395 >DOI >Link

Beynon CM, Sumnall HR, McVeigh J, Cole JC, Bellis MA. 2006. The ability of two commercially available quick test kits to detect drug-facilitated sexual assault drugs in beverages. Addiction, 101 :1413-1420 >DOI >Link

Beynon CM, Bellis MA, McVeigh J. 2006. Trends in drop out, drug free discharge and rates of re-presentation: a retrospective cohort study of drug treatment clients in the North West of England. BMC Public Health, 6 :205 >DOI >Link

Bellis MA, Hughes K, McVeigh J, Thomson R, Luke C. 2005. The effects of nightlife activity on health Nursing Standard, :63-71

Sumnall HR, Bellis MA, Cole JC, Mcveigh J. 2005. Crack-cocaine injection: A retrospective analysis of clients in Merseyside specialist drug treatment agencies DRUGS-EDUCATION PREVENTION AND POLICY, 12 :213-221 >DOI >Link

Hughes K, Bellis M, McVeigh J, Thomson R. 2004. A potent cocktail. Nurs Stand, 18 :14-16 >Link

McVeigh J, Beynon C, Bellis MA. 2003. New challenges for agency based syringe exchange schemes: analysis of 11 years of data (1991 to 2001) in Merseyside and Cheshire, UK. Int. J. Drug Pol., :399-405

Cook PA, McVeigh J, Syed Q, Mutton K, Bellis MA. 2001. Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment. Addiction, 96 :1787-1797 >DOI >Link

Bellis M, McVeigh J, Thomson R, Syed Q. 1999. AIDS funding. The national lottery. Health Serv J, 109 :22-23 >Link

McVeigh J. 1996. Survey of gym owners’ opinions on the use of performance enhancing drugs J. Perform. Enhanc. Drugs, :21-24

Lenehan P, Bellis MA, McVeigh J. 1996. A study of anabolic steroid use in the North West of England J. Perform. Enhanc. Drugs, :57-70

Korkia P, Lenehan P, McVeigh J. 1996. Non-medical use of androgens among women J. Perform. Enhanc. Drugs, :71-76

Other

Simkhada P, Poudel AN, Simkhada B, Sumnall H, Jones L, Bista S, McVeigh J, Gaidhane A, Zahiruddin QS, Chowdhury ME, Bhuiyan MBAS, Iliyasu Z, Pant PR, Kurmi O, Hill R, Van Teijlingen E, Regmi PR. 2016. Need and scope of global partnership on public health research Journal of Datta Meghe Institute of Medical Sciences University, 11 :260-262

Bates G, Jones L, Tod D, McVeigh J, Newson LM, Begley E. Investigating the application and effectiveness of behaviour change theories and techniques in interventions to prevent muscle enhancement drug use >Link

Editorials and letter to the editor

Simkhada P, Poudel AN, Simkhada B, Sumnall H, Jones L, Bista S, McVeigh J, Gaidhane A, Zahiruddin QS, Chowdhury ME, Bhuiyan MBAS, Iliyasu Z, Pant PR, Kurmi O, Hill R, van Teijlingen E, Regmi PR. 2016. Need and scope of global partnership on public health research Journal of Datta Meghe Institute of Medical Sciences University, 11 :202-204

Stensballe A, McVeigh J, Breindahl T, Kimergard A. 2015. SYNTHETIC GROWTH HORMONE RELEASERS DETECTED IN SEIZED DRUGS: NEW TRENDS IN THE USE OF DRUGS FOR PERFORMANCE ENHANCEMENT ADDICTION, 110 :368-369 >DOI >Link

Sumnall HR, Woolfall K, Cole J, Mackridge A, McVeigh J. 2008. Diversion and abuse of methylphenidate BMJ, 337 :1011

Sumnall HR, Woolfall K, Cole J, Mackridge A, McVeigh J. 2008. NICE GUIDANCE ON ADHD Diversion and abuse of methylphenidate BRITISH MEDICAL JOURNAL, 337 >DOI >Link

McVeigh J, Kimergard A, Bates G, Hope V, Ncube F. Focus on harm reduction in fight against HIV, says report BMJ-British Medical Journal,

Chapters

Sumnall H, McVeigh J, Evans-Brown MJ. 2013. Epidemiology of Use of Novel Psychoactive Substances Novel Psychoactive Substances: Classification, Pharmacology and Toxicology :79-103 9780124158160 >DOI

Evans-Brown M, Mcveigh J. 2009. Anabolic steroid use in the general population of the United Kingdom Dimeo P, McNamee M, Moller V. Elite Sport, Doping and Public Health :75-97 Univ Pr of Southern Denmark 9788776744106

McVeigh J. 2006. Introduction & Treatment Rateman S, Abdool R. Demand reduction training manual: Practical guidelines for effective interventions in drug abuse prevention, treatment and rehabilitation United Nations Office on Drugs and Crime. Dakar, Senegal

Conference Publication (journal proceedings)

Phillips B, Hamner J, Worthen N, Palmer S, Johnson K, Mulligan K, Baughman K, McVeigh J. 2009. Water board basics: Synchronous online training for small system boards American Water Works Association Annual Conference and Exposition 2009, ACE 2009,

Books

Lenehan P, McVeigh J. 1998. Anabolic Steroids: a guide for professionals University of Liverpool. Liverpool

Engagement & Impact

Conference organisation:

Conference name: National Needle Exchange Forum Conference, Position: Invited Speaker, URL: http://www.nnef.org.uk/index.php/past-events/17-meetingspast/106-high-wycombe

Conference name: Public Health & Enhancement Drugs Conference, Position: Chair and Speaker

Editorial boards:

Publication: UK Home Office, Position: Reviewer

Publication: UK National Drug Strategy, Position: Academic Reviewer

Publication: Blackwell Scientific Publications, Routledge Books, Position: Academic Book Reviewer

Publication: International Journal of Drug Policy, Position: Referee

Publication: Drug and Alcohol Today, Position: Referee

Publication: International Review for the Sociology of Sport, Position: Referee

Publication: Drug and Alcohol Dependence, Position: Referee

Publication: Journal of Epidemiology and Community Health, Position: Referee

Publication: British Journal of Sports Medicine, Position: Referee

Publication: Addiction, Position: Referee

Publication: Journal of Substance Use, Position: Editorial Board Member

External committees:

Committee name: High Level Expert Review Group, Organisation: EU Study on Doping Prevention

Committee name: National Evaluation of Health Action Zone, Organisation: Department of Health

Committee name: National Treatment Agency Expert Advisory Group, Organisation: National Treatment Agency

Committee name: United Nations Office on Drugs and Crime (West Africa), Organisation: United Nations

Committee name: Coastal and Ex Mining Drugs Projects, Organisation: Department of Health

Committee name: National Collaborative Centre for Drug Prevention, Organisation: Various

Committee name: Drug Futures Advisory Group, Organisation: Home Office

Committee name: North West Health and Social Care of Offenders Board, Organisation: Various

Committee name: Co-opted Advisory Council on the Misuse of Drugs - Anabolic Steroids, Organisation: Various

Committee name: Board of Trustees, Organisation: Independence Initiative

Committee name: International Network of Humanistic Doping, Organisation: Various

Committee name: International Conference Organizing Committee, Organisation: IHRA, Position: Chair

Committee name: Intelligence Network on Drug Related Harms, Organisation: Department of Health

Committee name: Drug Policy Advisory Group, Organisation: UK Faculty of Public Health